Targeting CDK9 for the Treatment of Glioblastoma

SIMPLE SUMMARY: Inhibition of cyclin-dependent kinase 9 (CDK9) can impact multiple survival pathways in cancers and may be a promising therapeutic approach for glioblastoma, which is known to be highly resistant to treatments and thus challenging to treat. This review assesses the mechanisms by whic...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cancers (Basel)
Prif Awduron: Ranjan, Alice, Pang, Ying, Butler, Madison, Merchant, Mythili, Kim, Olga, Yu, Guangyang, Su, Yu-Ting, Gilbert, Mark R., Levens, David, Wu, Jing
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: MDPI 2021
Pynciau:
Review
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8234280/
https://ncbi.nlm.nih.gov/pubmed/34207158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13123039
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg